Auxilius is the leading Clinical Trial Financial Management platform designed specifically for the needs of finance and accounting professionals in the biopharma industry. Tailored to the unique complexities of R&D, Auxilius complements existing FP&A, ERP, and clinical tools to help teams streamline processes like budgeting, forecasting, accruals, and vendor management. By providing transparency, control, and automation, Auxilius enables organizations to manage clinical trial finances more efficiently, mitigate risks, and ensure accurate financial reporting.

Auxilius Videos

As clinical-stage biotech companies look ahead to 2025, understanding the latest accounting, audit, and reporting challenges is essential for staying compliant and making informed financial decisions.

During this session Auxilius and Deloitte will cover key accounting and reporting updates that are critical to clinical-stage life science companies, while providing practical strategies for R\&D accruals and trial financial planning.

Topics Covered Include:

• Accounting & Reporting Update, including Segment Reporting ASU

• SEC Comment Letter Trends

• Critical Audit Matter Trends

• Public versus Private Company Considerations

• R\&D and Clinical Accrual Considerations

• Strategies to Address Challenging Accrual Scenarios: Investigator Spend

This webinar is designed for finance and accounting professionals in the biotech sector looking to stay ahead of regulatory changes and improve their financial processes.


Deloitte + Auxilius: Accounting & Finance for Clinical Stage Companies

Still unsure what R\&D accrual methodology you should use for your clinical trial?

Come join PMV Pharmaceuticals (PMVP) CFO, Michael Carulli and Auxilius President and COO, Erin Warner Guill as they discuss how to evaluate and evolve different R\&D accrual methodologies.

They will then discuss how PMV weighed and evolved its methodologies over time on the Auxilius platform.

Specific topics discussed:

*   The benefits and drawbacks of different accrual methodologies
*   How PMV Pharma decided which accrual methodology to use
*   How PMV Pharma evolved its accrual methodology over time
*   How the Auxilius platform supports a wide array of accrual methodologies


Determining the Best Expense Source in Accrual Preparation (With PMV Pharma)

Exploring the New Standard in Clinical Trial Accruals

Hear from two current Auxilius customers (Dynavax and Abcuro) about what it's like to implement and use Auxilius. Hosted by our own VP of Operations, Kristen Lueck.

Panelists:

*   Ricky Motschwiller, CPA, VP of Finance, Abcuro
*   David Chen, Director of R\&D Finance, Dynavax
*   Emily Tran, PMP, Senior Manager, Dynavax

In the session we will cover:

*   Why they chose to implement Auxilius when they did
*   What their implementation experience was like
*   Any advice they have for others biopharmas 


Customer Panel: Implementing and Using Auxilius

About

Speakers

David Chen

Director of R&D Finance and Global Operations Finance, Dynavax

Emily Tran

Senior Project Manager, Dynavax

Ricky Motschwiller, CPA

VP of Finance, Abcuro

Replays

Deloitte + Auxilius: Accounting & Finance for Clinical Stage Companies

Determining the Best Expense Source in Accrual Preparation (With PMV Pharma)

Exploring the New Standard in Clinical Trial Accruals